The maca protein ameliorates DSS-induced colitis in mice by modulating the gut microbiota and production of SCFAs

Ping He1, Yizhe Zhang1, Ruyang Chen1

  • 1College of Food Sciences and Engineering, South China University of Technology, Guangzhou 510640, China. fehwu@scut.edu.cn.

Food & Function
|November 13, 2023
PubMed

Insights

Maca protein (MCP) effectively reduced inflammation and colon damage in mice with inflammatory bowel disease (IBD). It also positively altered gut bacteria and promoted beneficial short-chain fatty acids (SCFAs), suggesting MCP as a potential functional food for gut health.

Area of Science:

  • Gastroenterology and Nutrition
  • Immunology and Microbiology

Background:

  • Inflammatory bowel disease (IBD) is a prevalent gastrointestinal condition with limited therapeutic options.
  • Maca, a functional food, possesses anti-inflammatory properties, but its protein component's effect on IBD is under-researched.
  • Maca protein (MCP) is a potential candidate for modulating gut health due to its rich protein content.

Purpose of the Study:

  • To investigate the therapeutic effects of maca protein (MCP) on dextran sodium sulfate (DSS)-induced inflammatory bowel disease (IBD) in a mouse model.
  • To elucidate the underlying mechanisms, including gut microbiota modulation, short-chain fatty acid (SCFA) production, and immune balance regulation.

Main Methods:

  • Extraction of maca protein (MCP) from maca root.
  • Induction of colitis in mice using dextran sodium sulfate (DSS).
  • Administration of MCP to DSS-treated mice.
  • Assessment of clinical symptoms, colon tissue damage, inflammatory factor expression, gut microbiota composition, SCFA levels, and Treg/Th17 immune balance via Western blotting.

Main Results:

  • MCP intervention significantly alleviated clinical symptoms and colon tissue damage in DSS-induced colitis mice.
  • MCP modulated gut microbiota by decreasing detrimental bacteria (e.g., *Bacteroides*, *Desulfovibrio*) and increasing beneficial bacteria (e.g., *Lactobacillus*, *Akkermansia*).
  • MCP promoted SCFA production and regulated the Treg/Th17 immune balance through the SCFAs-GPR41/43/HDAC1 signaling pathway.

Conclusions:

  • Maca protein (MCP) demonstrates significant anti-inflammatory effects in a mouse model of IBD.
  • MCP alleviates colitis by comprehensively regulating gut microbiota, promoting SCFA production, and balancing the immune response.
  • MCP holds promise as a functional food component for maintaining intestinal health and reducing colitis risk.